Awh Capital, L.P. Aptinyx Inc. Transaction History

Awh Capital, L.P.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.38 - $2.58 $186,145 - $1.26 Million	-489,856 Closed	0 $0
Q1 2022 Jun 14, 2023	BUY	$2.27 - $3.62 $1.11 Million - $1.77 Million	489,856 New	489,856 $1.11 Million
Q1 2022 May 16, 2022	SELL	$2.27 - $3.62 $420,276 - $670,221	-185,144 Reduced 27.43%	489,856 $1.11 Million
Q2 2021 Aug 16, 2021	BUY	$2.39 - $3.5 $45,410 - $66,500	19,000 Added 2.9%	675,000 $1.91 Million
Q1 2021 May 17, 2021	BUY	$2.86 - $4.33 $381,810 - $578,055	133,500 Added 25.55%	656,000 $1.97 Million
Q4 2020 Feb 16, 2021	BUY	$2.93 - $4.3 $1.53 Million - $2.25 Million	522,500 New	522,500 $1.81 Million

Ticker APTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,715,696
Description
Aptinyx Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel, proprietary, and synthetic small molecules for the treatment of brain and nervous system disorders. The company is developing NYX-2925, which is in Phase II clinical development for the treatment of painful diabetic pe...

Get notified when there are updates to the investment portfolio of Awh Capital, L.P., based on Form 13F filings with the SEC.

Stay updated on Awh Capital, L.P. with notifications on news.